Results 181 to 190 of about 17,340 (217)
Some of the next articles are maybe not open access.
[Viral hemorrhagic fever--Ebola hemorrhagic fever, Marburg disease and Lassa fever].
Rinsho byori. The Japanese journal of clinical pathology, 1998Viral hemorrhagic fevers include Ebola hemorrhagic fever, Marburg disease and Lassa fever. The etiologic agents of the diseases, Ebola virus, Marburg virus and Lassa virus, respectively, are categorized as viruses with biosafety level 4, because of their high mortality, high transmissibility and the lack of effective vaccines and therapeutic measures ...
openaire +1 more source
Comparative Pathogenesis of Crimean-Congo Hemorrhagic Fever and Ebola Hemorrhagic Fever
2007Crimean-Congo hemorrhagic fever (CCHF) virus has been called “the Asian Ebola virus” – an epithet that recognizes the close clinical resemblance of CCHF and Ebola hemorrhagic fever (EHF), and also suggests that the two illnesses share similar underlying mechanisms [38]. CCHF and EHF both present difficult challenges to pathophysiology research, because
openaire +1 more source
Viral Hemorrhagic Fevers (Ebola, Lassa, Hantavirus)
2016Viral hemorrhagic fever (VHF) designates diseases caused by enveloped, single-stranded RNA viruses belonging to the families Ebola, Lassa, Hantavirus, and yellow fever. Unifying features include fever, capillary leak, and coagulation defects. These viruses can affect all organ systems; transmission occurs via contact with rodent excretions, either by ...
openaire +1 more source
Viral genomics in Ebola virus research
Nature Reviews Microbiology, 2020Nicholas Di Paola +2 more
exaly
Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus
Nature Reviews Microbiology, 2015Ilhem Messaoudi +2 more
exaly
Post-exposure treatments for Ebola and Marburg virus infections
Nature Reviews Drug Discovery, 2018Robert W Cross +2 more
exaly
Therapeutic strategies to target the Ebola virus life cycle
Nature Reviews Microbiology, 2019Thomas Hoenen +2 more
exaly